Merck KGaA's Outlook Continues to Be Good: CFO

The video discusses the company's positive outlook, driven by strong growth in the life sciences division, particularly due to COVID-19 related products. It highlights the expected continuation of this trend into 2022, with a focus on vaccinations and boosters. The video also addresses supply chain challenges, especially in semiconductors, and outlines the company's strategy for managing these issues. Finally, it covers the company's portfolio strategy, emphasizing a focus on bolt-on acquisitions rather than major transformational deals.

How is the company managing supply chain issues and inflation?

What is the company's strategy regarding acquisitions in the healthcare sector?

What areas of technology is the company focusing on for future growth?